Business Description
Immunome Inc
NAICS : 541714
SIC : 2833
ISIN : US45257U1088
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 86.15 | |||||
Equity-to-Asset | 0.81 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.06 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 14.45 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 34.5 | |||||
3-Year EPS without NRI Growth Rate | 28.8 | |||||
3-Year FCF Growth Rate | 51.7 | |||||
3-Year Book Growth Rate | -10.7 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 4.79 | |||||
9-Day RSI | 12.34 | |||||
14-Day RSI | 21.23 | |||||
6-1 Month Momentum % | 169.06 | |||||
12-1 Month Momentum % | 332.43 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.63 | |||||
Quick Ratio | 6.63 | |||||
Cash Ratio | 6.51 | |||||
Days Sales Outstanding | 17.73 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -59.6 | |||||
Shareholder Yield % | -0.05 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -204.94 | |||||
Net Margin % | -761.92 | |||||
FCF Margin % | -59.92 | |||||
ROE % | -322.07 | |||||
ROA % | -150.31 | |||||
ROIC % | -168.42 | |||||
ROC (Joel Greenblatt) % | -1662.12 | |||||
ROCE % | -57.04 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 15.17 | |||||
PB Ratio | 5.02 | |||||
Price-to-Tangible-Book | 5.02 | |||||
Price-to-Free-Cash-Flow | 38.56 | |||||
Price-to-Operating-Cash-Flow | 34.29 | |||||
EV-to-EBIT | -24.71 | |||||
EV-to-EBITDA | -25.36 | |||||
EV-to-Revenue | 50.65 | |||||
EV-to-FCF | -84.69 | |||||
Price-to-Net-Current-Asset-Value | 5.19 | |||||
Price-to-Net-Cash | 5.31 | |||||
Earnings Yield (Greenblatt) % | -4.05 | |||||
FCF Yield % | -1.01 |